全球蛋白質印跡市場：規模/份額/趨勢分析（產品/應用程序/最終用戶）、區域展望、競爭戰略、分部預測（至 2030 年）

全球蛋白質印跡市場預計將以 5.9% 的複合年增長率增長，到 2030 年將達到 16 億美元。主要市場驅動因素包括全球艾滋病毒/艾滋病流行、生物醫學領域資金增加、向個性化醫療轉變以及技術進步。

本報告分析了全球蛋白質印跡市場，包括市場基本結構、主要影響因素、整體市場規模趨勢展望（2019-2030）、產品類型、應用和終端。我們正在按用戶調查詳細趨勢及地區、主要公司概況等。

目錄

第一章介紹

第二章調查方法

第 3 章執行摘要

第 4 章市場概述

• 簡介
• 市場動態
  • 促進因素
  • 抑制器
  • 市場機會
  • 挑戰
• COVID-19：對蛋白質印跡市場的影響
• 市場趨勢

第 5 章全球蛋白質印跡市場：按產品類型（100 萬美元，2019-2030 年）

• 消耗品
  • 抗體/複合物
  • 套件
  • 濾膜/濾紙
  • 其他耗材
  • 試劑/緩衝液
• 設備
  • 電泳裝置
  • 印跡裝置
  • 成像設備

第 6 章全球蛋白質印跡市場：按用途（100 萬美元，2019-2030 年）

• 農業用途
• 生物醫學研究
• 臨床診斷
  • 肝炎
  • 艾滋病毒
  • 萊姆病
  • 其他疾病
• 其他用途

第 7 章全球蛋白質印跡市場：按最終用戶分類（100 萬美元，2019-2030 年）

• 教育/研究
• 生物製藥/生物技術公司
• 醫院/診斷實驗室
• 其他最終用戶

第 8 章按地區分列的全球蛋白質印跡市場（100 萬美元，2019-2030）

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東
• 非洲

第9章競爭態勢

• 簡介
• 市場份額分析：按主要公司
• 衝突場景
  • 產品發布
  • 夥伴關係、合作、合同
  • 收購
  • 擴展
  • 其他趨勢

第 10 章公司簡介

• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Danaher Corporation
• Merck KGaA
• Thermo Fisher Scientific

第11章 附錄

Global Western Blotting Market is projected to be worth USD 1.6 billion by 2030.

According to SPER Market Research, the Western Blotting Market to reach USD 1.6 billion by 2030 with a CAGR of 5.9%. The prevalence of HIV/AIDS worldwide, increase funding in biomedical sector, and shift towards personalized medicine, technological advancements; are the growths driving factors.

Impact of COVID-19 on the the Western Blotting Market

Because of the increased awareness about the infection, research work also increased. Due to COVID-19 epidemic, testing, diagnosing of the infection increased by the companies. That leads to huge opportunities for companies to make profits.

Scope of the report:

• Market size available for years:2019-2030
• Base year considered: 2021
• Forecast period: 2022-2030

Segments covered

• By Product, By Application, By End Users, By Region

Geographies covered

• North America, Europe, Asia Pacific, Latin America , and MEA

Companies Covered

• Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific

Driver: Technological advancements

Rising incidences of HIV/AIDS globally gave impetus for the advancement and up gradation of technologies, there increased demand for personalized medicine in turn funding of government in Biomedical Research, these are the key elements for the growth of this market.

Restraint: Emergence of alternative technologies

Alternative technologies (ELISA, LC/MS, and LFIA) are user friendly, high accuracy, Precision, high speed, consistency, sensitivity, and can handle multiple samples as compared to existing technologies (Western Blotting).

Challenges: Requirement of high procedural efficiency for accurate results

To get a reliable, quantitative result there is need of high efficiency, precise methodology, analytical knowledge, widespread labour-intensive managing, handiness, and firm observance of protocols. The data variations & Failure rates are high in Western Blotting.

Opportunity: Emerging economies

There will be huge opportunities in the Asia Pacific, Latin America, the Middle East & Africa, due to increasing the innovation in the research & development, health care market, personalized medicine, developments in research infrastructure and the economical manufacturing cost of emerging APAC countries encourage market players to invest.

Global Western Blotting Market, by Product:

Based upon the product, the Global western blotting market is segmented as; Consumables (Reagents & Buffers, Antibodies & Conjugates, Kits, Membranes & Filter Papers, Other Consumables), Instruments {Electrophoresis Instruments, Blotting Systems, Imagers (Chemiluminescent Imagers, Fluorescent Imagers, Other Imagers)}.

Global Western Blotting Market, by Application:

Based upon the Application, the Global western blotting market is segmented as; Biomedical Research, Clinical Diagnostics (Hepatitis, HIV, Lyme disease, Other Diseases), Agricultural Applications, Other Applications

Global Western Blotting Market, by End Users

Based upon the End Users, the Global western blotting market is segmented as; Academic & Research Institutes, Biopharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Other End Users.

Global Western Blotting Market, by Region:

North America dominates the highest share of this market, is due to the presence of big companies, increase in investment in biomedical research, and demand for personalized medicine.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Dynamics
  • 4.2.1. Drivers
  • 4.2.2. Restraints
  • 4.2.3. Opportunities
  • 4.2.4. Challenges
• 4.3. COVID-19 Impact on the Western Blotting Market
• 4.4. Market Trends

5. Global Western Blotting Market, By Product Type, 2019-2030 (USD Million)

• 5.1. Consumables
  • 5.1.1. Antibodies & Conjugates
  • 5.1.2. Kits
  • 5.1.3. Membranes & Filter Papers
  • 5.1.4. Other Consumables
  • 5.1.5. Reagents & Buffers
• 5.2. Instruments
  • 5.2.1. Electrophoresis Instruments
  • 5.2.2. Blotting Systems
  • 5.2.3. Imagers
    • 5.2.3.1. Chemiluminescent Imagers
    • 5.2.3.2. Fluorescent Imagers
    • 5.2.3.3. Other Imagers

6. Global Western Blotting Market, By Application, 2019-2030 (USD Million)

• 6.1. Agricultural Applications
• 6.2. Biomedical Research
• 6.3. Clinical Diagnostics
  • 6.3.1. Hepatitis
  • 6.3.2. HIV
  • 6.3.3. Lyme disease
  • 6.3.4. Other Diseases
• 6.4. Other Applications

7. Global Western Blotting Market, By End Users, 2019-2030 (USD Million)

• 7.1. Academic & Research Institutes
• 7.2. Biopharmaceutical & Biotechnology Companies
• 7.3. Hospitals & Diagnostic Laboratories
• 7.4. Other End Users

8. Global Western Blotting Market, By Region, 2019-2030 (USD Million)

• 8.1. North America
• 8.2. Europe
• 8.3. Asia Pacific
• 8.4. Latin America
• 8.5. The middle East
• 8.6. Africa

9. Competitive Landscape

• 9.1. Introduction
• 9.2. Market Share Analysis, By Key Players
• 9.3. Competitive Scenario
  • 9.3.1. Product Launches
  • 9.3.2. Partnerships, Collaborations and Agreements
  • 9.3.3. Acquisitions
  • 9.3.4. Expansions
  • 9.3.5. Other Developments

10. Company Profiles

• 10.1. Bio-Rad Laboratories, Inc.
• 10.2. Bio-Techne Corporation
• 10.3. Danaher Corporation
• 10.4. Merck KGaA
• 10.5. Thermo Fisher Scientific

11. Appendix